404 ERROR

Indication

ZIRGAN^® (ganciclovir ophthalmic gel) 0.15% is a topical ophthalmic antiviral that is indicated for the treatment of acute herpetic keratitis (dendritic ulcers).

Important Safety Information

• ZIRGAN^® is indicated for topical ophthalmic use only.
• Patients should not wear contact lenses if they have signs or symptoms of herpetic keratitis or during the course of therapy with ZIRGAN^®.
• Most common adverse reactions reported in patients were blurred vision (60%), eye irritation (20%), punctate keratitis (5%), and conjunctival hyperemia (5%).
• Safety and efficacy in pediatric patients below the age of 2 years have not been established.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.1-800-FDA-1088.

Click here for full Prescribing Information for ZIRGAN^®.

ZIRGAN^® is a trademark of Laboratoires Théa Corporation used under license.